B. Riley Asset Management »

Peregrine Pharmaceuticals shares owned by B. Riley Asset Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by B. Riley Asset Management from 13F filings

Historical chart of B. Riley Asset Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by B. Riley Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by B. Riley Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9M 580k 6.81
2023-09-30 $1.0M 111k 9.44
2023-06-30 $1.0M 73k 13.97

More positions owned by B. Riley Asset Management

Sequans Communications S A Sponsored Ads (SQNS)
CalAmp
Vishay Precision (VPG)
Harvard Bioscience (HBIO)
Applied Digital Corp Com New (APLD)
Walkme Ord Shs (WKME)
Cadiz Com New (CDZI)
Riskified Shs Cl A (RSKD)
Magnachip Semiconductor Corp (MX)
Mitek Sys Com New (MITK)
Everbridge, Inc. Cmn (EVBG)
Xperi Common Stock (XPER)
Upland Software (UPLD)
8x8 (EGHT)
Aviat Networks Com New (AVNW)

View all positions for B. Riley Asset Management

Top funds holding Peregrine Pharmaceuticals

Millennium Management
Vanguard Group
AltraVue Capital
Royal Bank of Canada
Palisade Capital Management
Wellington Management Company
Punch & Associates Investment Management
AWM Investment Company
Kornitzer Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Sargent Investment Group
Goldman Sachs Group
B. Riley Asset Management
Two Sigma Investments

View all funds holding Peregrine Pharmaceuticals